| Stakeholders | Roles |
---|---|---|
Donors | Global Fund | Funding the policy change |
WHO | Providing evidence and technical assistance (TA), participating in the policy process, funding research | |
UNICEF | Providing evidence, participating in the policy process | |
Presidential Malaria Initiative/USAID | Funding research and participating in the policy process | |
Department for International Development (DFID) from the UK | Funding research and participating in the policy process | |
China | Providing free medicines (AL) | |
Pharmaceutical companies | NOVARTIS | Manufacturing the drug |
Private pharmaceutical companies | Importing drugs | |
Public sector | Top management of MoH | Decision making |
Technical programmes within MoH | Adapting and implementing the policy, participating in research processes, and disseminating evidence | |
Ministry of Finance | Providing funding | |
Parliamentarians | Disseminating evidence and information on the policy change | |
Service providers at national referral institutions | Providing evidence, participating in the policy process | |
Service providers at lower levels | Implementing the new policy | |
NDA | Regulating medicines | |
National Medical Store and Joint Medical Store | Supplying drugs | |
 | Researchers in universities | Providing evidence and participating in the policy process |
Community | The community | Beneficiaries of the policy change |
Local leaders | Opinion leaders at national level | Disseminating information on the policy change |
Leaders at the local level | Disseminating information on the policy change | |
Private sectors | CSOs | Participating in policy discussions, research, advocacy, and implementation and monitoring of the new policy |
Private practitioners | Implementing the new policy | |
Researchers from private research institutions | Providing evidence and participating in the policy process | |
Private sector—companies | Advocacy, publicity, donations |